JOHN W KOZARICH Insider Trading $RTRX Travere Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN W KOZARICH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN W KOZARICH. JOHN W KOZARICH is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Director in QLT INC/BC ($QLTI) and Director in Retrophin, Inc. ($RTRX) and Director in Intec Pharma Ltd. ($NTEC).

JOHN W KOZARICH in Travere Therapeutics, Inc.

Trading Symbol: RTRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN W KOZARICH: Director
Holdings: 29,000 shares
Current Value: $582,030
Latest Transaction: May 10 2019
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN W KOZARICH in Travere Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, NTEC, LGND, NVLN, RTRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 10 2019RTRXRetrophin, Inc.KOZARICH JOHN WDirectorOption ExerciseA17.948,000143,5208,000
May 10 2019RTRXRetrophin, Inc.KOZARICH JOHN WDirectorGrantA0.002,000029,00027 K to 29 K (+7.41 %)
May 11 2018RTRXRetrophin, Inc.KOZARICH JOHN WDirectorOption ExerciseA26.5210,000265,20010,000
May 11 2018RTRXRetrophin, Inc.KOZARICH JOHN WDirectorGrantA0.002,500027,00024.5 K to 27 K (+10.20 %)
May 18 2017RTRXRetrophin, Inc.KOZARICH JOHN WDirectorOption ExerciseA17.4410,000174,40010,000
May 18 2017RTRXRetrophin, Inc.KOZARICH JOHN WDirectorGrantA0.002,500024,50022 K to 24.5 K (+11.36 %)
May 19 2016RTRXRetrophin, Inc.KOZARICH JOHN WDirectorOption ExerciseA16.338,000130,6408,000
May 19 2016RTRXRetrophin, Inc.KOZARICH JOHN WDirectorGrantA0.002,000022,00020 K to 22 K (+10.00 %)
Apr 03 2015RTRXRetrophin, Inc.KOZARICH JOHN WDirectorOption ExerciseA23.6140,000944,40040,000
Apr 03 2015RTRXRetrophin, Inc.KOZARICH JOHN WDirectorGrantA0.0020,000020,0000 to 20 K

Page:   1